The report found that franchise expansion was the leading mode of market entry however, organic growth and website launches accounted for the vast majority of the other market entries during this period.
Datamonitor, a New York-based market analysis firm, noted in a report, published March 2001, of an industry shift towards "high-barrier-to-entry generic products, " or specialty generic pharmaceuticals.